🇺🇸 FDA
Pipeline program

DISC-3405

DISC-3405-102

Phase 1 small_molecule active

Quick answer

DISC-3405 for Sickle Cell Disease is a Phase 1 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Sickle Cell Disease
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials